Literature DB >> 12020519

Hormonal therapy for gastrointestinal angiodysplasia.

Humphrey Hodgson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020519     DOI: 10.1016/S0140-6736(02)08542-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapy.

Authors:  J Molina-Infante; B Perez-Gallardo; G Gonzalez-Garcia; M Fernandez-Bermejo; J M Mateos-Rodriguez; P Robledo-Andres
Journal:  Gut       Date:  2007-03       Impact factor: 23.059

2.  Rendu-Osler disease: treatment with oestrogen/progestagen versus octreotide.

Authors:  Séverin Jeanneret; Loic Regazzoni; Bernard Favrat
Journal:  BMJ Case Rep       Date:  2011-02-23

3.  Lower gastrointestinal bleeding in chronic hemodialysis patients.

Authors:  Fahad Saeed; Nikhil Agrawal; Eugene Greenberg; Jean L Holley
Journal:  Int J Nephrol       Date:  2011-10-05

4.  Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study.

Authors:  Robert Benamouzig; Mourad Benallaoua; Jean-Christophe Saurin; Marouane Boubaya; Christophe Cellier; René Laugier; Magalie Vincent; Christian Boustière; Rodica Gincul; Elia Samaha; Philippe Grandval; Thomas Aparicio; Gheorghe Airinei; Bakhtiar Bejou; Cyriaque Bon; Jean-Jacques Raynaud; Vincent Levy; Denis Sautereau
Journal:  Therap Adv Gastroenterol       Date:  2018-02-16       Impact factor: 4.409

Review 5.  Diagnostic and therapeutic considerations for obscure gastrointestinal bleeding in patients with chronic kidney disease.

Authors:  Mayssan Muftah; Ramzi Mulki; Tanvi Dhere; Steven Keilin; Saurabh Chawla
Journal:  Ann Gastroenterol       Date:  2018-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.